| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |